TAPIMMUNE
TapImmune engages in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. The company focuses on conducting studies using its transporters of antigen processing (TAP) gene technology in combination with an adeno virus. Its products include TAP cancer vaccine used for the treatment of breast cancer, prostate cancer, lung cancer, liver cancer, melanoma, renal cancer, and colorectal cancer. The c... ompany also develops vaccines for infectious diseases using its TAP gene technology. TapImmune has strategic relationships with University of British Columbia, Crucell Holland B.V., SAFC Pharma, Inc., and National Institute of Allergy and Infectious Diseases. The company was founded in 1999 and is based in Vancouver, Canada.
TAPIMMUNE
Industry:
Biotechnology Genetics Therapeutics
Founded:
1999-01-01
Address:
Jacksonville, Florida, United States
Country:
United States
Website Url:
http://www.tapimmune.com
Total Employee:
11+
Status:
Closed
Contact:
(866)359-7541
Email Addresses:
[email protected]
Total Funding:
8.56 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Facebook Sharer QUIC CPanel GoDaddy Email Accelerated Mobile Pages SiteGround VPS
Similar Organizations
Eureka Genomics
Eureka Genomics develops diagnostics to detect inherited genetic traits, cancers, and infectious diseases in humans, animals, and crops.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Stock Details
Investors List
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - TapImmune
Official Site Inspections
http://www.tapimmune.com
- Host name: vmi1998508.contaboserver.net
- IP address: 109.199.113.10
- Location: Chicago United States
- Latitude: 41.8483
- Longitude: -87.6517
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60602
